News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
199,435 Results
Type
Article (20914)
Company Profile (27)
Press Release (178494)
Section
Business (50581)
Career Advice (327)
Deals (7206)
Drug Delivery (38)
Drug Development (25837)
Employer Resources (31)
FDA (5444)
Job Trends (4392)
News (89697)
Policy (8364)
Tag
Academia (1869)
Alliances (15499)
Alzheimer's disease (528)
Approvals (5438)
Artificial intelligence (68)
Bankruptcy (58)
Best Places to Work (3757)
Breast cancer (70)
Cancer (529)
Cardiovascular disease (109)
Career advice (296)
CAR-T (35)
Cell therapy (108)
Clinical research (20231)
Collaboration (188)
COVID-19 (1196)
C-suite (47)
Data (493)
Denatured (35)
Diabetes (50)
Diagnostics (1952)
Drug pricing (37)
Earnings (13020)
Events (25097)
Executive appointments (137)
FDA (5693)
Funding (225)
Gene therapy (80)
GLP-1 (215)
Government (1508)
Healthcare (6221)
Infectious disease (1227)
Interviews (36)
IPO (3352)
Job creations (790)
Job search strategy (271)
Layoffs (76)
Legal (1548)
Lung cancer (81)
Lymphoma (37)
Manufacturing (58)
Medical device (4022)
Medtech (4022)
Mergers & acquisitions (3949)
Metabolic disorders (149)
Neuroscience (630)
NextGen: Class of 2025 (2073)
Non-profit (2389)
Northern California (470)
Obesity (85)
Opinion (61)
People (17931)
Phase I (6085)
Phase II (8753)
Phase III (6797)
Pipeline (161)
Podcasts (93)
Policy (56)
Postmarket research (1211)
Preclinical (2787)
Radiopharmaceuticals (59)
Rare diseases (82)
Real estate (1602)
Regulatory (5805)
Research institute (1938)
Series A (39)
Southern California (411)
Startups (1324)
The Weekly (57)
United States (4669)
Vaccines (231)
Weight loss (63)
Date
Today (39)
Last 7 days (118)
Last 30 days (519)
Last 365 days (9919)
2025 (457)
2024 (10014)
2023 (11634)
2022 (15224)
2021 (16674)
2020 (15890)
2019 (14535)
2018 (10900)
2017 (9678)
2016 (9900)
2015 (11635)
2014 (8686)
2013 (7374)
2012 (7688)
2011 (8028)
2010 (7501)
Location
Africa (235)
Arizona (69)
Asia (11345)
Australia (2514)
California (1067)
Canada (497)
China (80)
Colorado (61)
Connecticut (43)
Delaware (37)
Europe (25850)
Florida (186)
Illinois (141)
Indiana (61)
Japan (35)
Maryland (170)
Massachusetts (848)
Minnesota (100)
New Jersey (424)
New York (373)
North Carolina (252)
Northern California (470)
Ohio (56)
Pennsylvania (231)
South America (333)
Southern California (411)
Texas (213)
Washington State (130)
199,435 Results for "montreal heart institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
FDA
The Montreal Heart Institute Welcomes FDA Approval of Colchicine for the Treatment of Cardiovascular Diseases
The Montreal Heart Institute (MHI) welcomes the approval by the United States Food and Drug Administration (FDA) of colchicine for cardiovascular prevention.
June 23, 2023
·
2 min read
Press Releases
FDA Grants Orphan Drug Designation to IPS HEART’s GIVI-MPC Stem Cell Therapy for Becker Muscular Dystrophy
January 13, 2025
·
2 min read
Press Releases
ZOLL Enrolls First Patient in Groundbreaking SSCORE Commercial Registry at Minneapolis Heart Institute at Abbott Northwestern Hospital (Minneapolis, MN)
September 24, 2024
·
5 min read
GLP-1
Evidence Mounts for Benefit of GLP-1s Against Heart Disease
Expanding volumes of data point to mechanisms beyond weight loss and blood sugar control that contribute to cardiovascular benefits in the world’s fastest-growing drug class.
January 6, 2025
·
6 min read
·
Kate Goodwin
SeaStar Medical Announces $3.6 Million NIH Grant Award to Study the Selective Cytopheretic Device in Adult Patients with Severe Chronic Heart Failure
SeaStar Medical Holding Corporation announces that the National Institutes of Health’s (NIH) National Heart, Lung, and Blood Institute has awarded a $3.6 million grant for a clinical trial to evaluate the Selective Cytopheretic Device Adult (SCD-ADULT.
April 30, 2024
·
8 min read
Series A
MyoKardia Alumni Launch Kardigan with $300M to Tackle Heart Disease
After the successful development of mavacamten and the sale of MyoKardia to BMS in 2020, former executives of the biotech are back together with a mission to make cardiovascular disease curable and preventable.
January 10, 2025
·
2 min read
·
Heather McKenzie
Press Releases
INTASYL Technology and Compounds to be Focus of Presentation at 20th Annual Meeting of Oligonucleotide Therapeutics Society
--Data will be presented at the conference in October in Montreal
September 25, 2024
·
3 min read
Cardiovascular disease
Rivus Targets Weight-Loss Drug Market With Mid-Stage Win in Obesity-Related Heart Failure
Rivus Pharmaceuticals will push HU6 into Phase III development and is looking to engage with regulatory authorities and launch a late-stage study next year in obesity-related heart failure with preserved ejection fraction.
August 14, 2024
·
2 min read
·
Tristan Manalac
Press Releases
FIRE1 Secures $120 Million Financing to Revolutionize Heart Failure Care
January 7, 2025
·
3 min read
Press Releases
Axsendo Clinical Research (ACR) is proud to announce a new research partnership with Peak Heart & Vascular
January 15, 2025
·
1 min read
1 of 19,944
Next
